ContraFect Corporation (CFRXQ)

ContraFect Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Selling, General & Admin	11.74	12.15	11.76	11.63	9.81	8.71
Research & Development	18.47	44.74	35.51	22.61	18.06	22.42
Other Operating Expenses	0	7.72	0	0	0	0
Operating Expenses	30.21	64.61	47.27	34.24	27.87	31.12
Operating Income	-30.21	-64.61	-47.27	-34.24	-27.87	-31.12
Other Expense / Income	-6.08	0.55	-26.98	-6.08	-15.07	6.56
Pretax Income	-24.14	-65.15	-20.28	-28.16	-12.79	-37.68
Net Income	-24.14	-65.15	-20.28	-28.16	-12.79	-37.68
Shares Outstanding (Basic)	11	1	0	0	0	0
Shares Outstanding (Diluted)	11	1	0	0	0	0
Shares Change	2077.43%	13.41%	61.56%	174.80%	8.90%	36.81%
EPS (Basic)	-15.30	-124.97	-44.12	-98.95	-123.20	-396.00
EPS (Diluted)	-15.30	-124.97	-44.12	-98.95	-123.20	-396.00
Free Cash Flow	-35.65	-46.04	-41.13	-33.19	-27.45	-26.39
Free Cash Flow Per Share	-3.33	-88.30	-89.46	-116.63	-265.09	-277.58
EBITDA	-23.98	-65	-20.13	-27.99	-12.63	-37.53
Depreciation & Amortization	0.16	0.15	0.15	0.17	0.17	0.15
EBIT	-24.14	-65.15	-20.28	-28.16	-12.79	-37.68

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).